CAH Quote, Financials, Valuation and Earnings

Cencora, Inc. has a net margin of 0.72% compared to Cardinal Health, Inc.'s net margin of 0.66%. Cardinal Health, Inc.'s return on equity of -- beat Cencora, Inc.'s return on equity of 107.99%.

Cardinal Health, Inc. has a consensus price target of $247.80, signalling upside risk potential of 12.23%. On the other hand Cencora, Inc. has an analysts' consensus of $403.20 which suggests that it could grow by 11.74%. Given that Cardinal Health, Inc. has higher upside potential than Cencora, Inc., analysts believe Cardinal Health, Inc. is more attractive than Cencora, Inc..

Cardinal Health, Inc. has a beta of 0.642, which suggesting that the stock is 35.798% less volatile than S&P 500. In comparison Cencora, Inc. has a beta of 0.676, suggesting its less volatile than the S&P 500 by 32.374%.

Cardinal Health, Inc. has a quarterly dividend of $0.51 per share corresponding to a yield of 0.92%. Cencora, Inc. offers a yield of 0.64% to investors and pays a quarterly dividend of $0.60 per share. Cardinal Health, Inc. pays 31.43% of its earnings as a dividend. Cencora, Inc. pays out 27.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Cardinal Health, Inc. quarterly revenues are $65.6B, which are smaller than Cencora, Inc. quarterly revenues of $85.9B. Cardinal Health, Inc.'s net income of $471M is lower than Cencora, Inc.'s net income of $566.1M. Notably, Cardinal Health, Inc.'s price-to-earnings ratio is 31.77x while Cencora, Inc.'s PE ratio is 43.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardinal Health, Inc. is 0.22x versus 0.22x for Cencora, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

CVS Health Corp. has a net margin of 0.72% compared to Cardinal Health, Inc.'s net margin of 2.77%. Cardinal Health, Inc.'s return on equity of -- beat CVS Health Corp.'s return on equity of 2.28%.

Cardinal Health, Inc. has a consensus price target of $247.80, signalling upside risk potential of 12.23%. On the other hand CVS Health Corp. has an analysts' consensus of $94.84 which suggests that it could grow by 20.85%. Given that CVS Health Corp. has higher upside potential than Cardinal Health, Inc., analysts believe CVS Health Corp. is more attractive than Cardinal Health, Inc..

Cardinal Health, Inc. has a beta of 0.642, which suggesting that the stock is 35.798% less volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.496, suggesting its less volatile than the S&P 500 by 50.368%.

Cardinal Health, Inc. has a quarterly dividend of $0.51 per share corresponding to a yield of 0.92%. CVS Health Corp. offers a yield of 3.39% to investors and pays a quarterly dividend of $0.67 per share. Cardinal Health, Inc. pays 31.43% of its earnings as a dividend. CVS Health Corp. pays out 191.23% of its earnings as a dividend. Cardinal Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CVS Health Corp.'s is not.

Cardinal Health, Inc. quarterly revenues are $65.6B, which are smaller than CVS Health Corp. quarterly revenues of $105.7B. Cardinal Health, Inc.'s net income of $471M is lower than CVS Health Corp.'s net income of $2.9B. Notably, Cardinal Health, Inc.'s price-to-earnings ratio is 31.77x while CVS Health Corp.'s PE ratio is 56.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardinal Health, Inc. is 0.22x versus 0.25x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

McKesson Corp. has a net margin of 0.72% compared to Cardinal Health, Inc.'s net margin of 1.18%. Cardinal Health, Inc.'s return on equity of -- beat McKesson Corp.'s return on equity of --.

Cardinal Health, Inc. has a consensus price target of $247.80, signalling upside risk potential of 12.23%. On the other hand McKesson Corp. has an analysts' consensus of $974.40 which suggests that it could grow by 4.24%. Given that Cardinal Health, Inc. has higher upside potential than McKesson Corp., analysts believe Cardinal Health, Inc. is more attractive than McKesson Corp..

Cardinal Health, Inc. has a beta of 0.642, which suggesting that the stock is 35.798% less volatile than S&P 500. In comparison McKesson Corp. has a beta of 0.405, suggesting its less volatile than the S&P 500 by 59.521%.

Cardinal Health, Inc. has a quarterly dividend of $0.51 per share corresponding to a yield of 0.92%. McKesson Corp. offers a yield of 0.33% to investors and pays a quarterly dividend of $0.82 per share. Cardinal Health, Inc. pays 31.43% of its earnings as a dividend. McKesson Corp. pays out 10.69% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Cardinal Health, Inc. quarterly revenues are $65.6B, which are smaller than McKesson Corp. quarterly revenues of $106.2B. Cardinal Health, Inc.'s net income of $471M is lower than McKesson Corp.'s net income of $1.3B. Notably, Cardinal Health, Inc.'s price-to-earnings ratio is 31.77x while McKesson Corp.'s PE ratio is 26.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardinal Health, Inc. is 0.22x versus 0.29x for McKesson Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Pineapple, Inc. has a net margin of 0.72% compared to Cardinal Health, Inc.'s net margin of -184.62%. Cardinal Health, Inc.'s return on equity of -- beat Pineapple, Inc.'s return on equity of --.

Cardinal Health, Inc. has a consensus price target of $247.80, signalling upside risk potential of 12.23%. On the other hand Pineapple, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Cardinal Health, Inc. has higher upside potential than Pineapple, Inc., analysts believe Cardinal Health, Inc. is more attractive than Pineapple, Inc..

Cardinal Health, Inc. has a beta of 0.642, which suggesting that the stock is 35.798% less volatile than S&P 500. In comparison Pineapple, Inc. has a beta of 41.097, suggesting its more volatile than the S&P 500 by 4009.732%.

Cardinal Health, Inc. has a quarterly dividend of $0.51 per share corresponding to a yield of 0.92%. Pineapple, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardinal Health, Inc. pays 31.43% of its earnings as a dividend. Pineapple, Inc. pays out -- of its earnings as a dividend. Cardinal Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Cardinal Health, Inc. quarterly revenues are $65.6B, which are larger than Pineapple, Inc. quarterly revenues of $1.3K. Cardinal Health, Inc.'s net income of $471M is higher than Pineapple, Inc.'s net income of -$2.4K. Notably, Cardinal Health, Inc.'s price-to-earnings ratio is 31.77x while Pineapple, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardinal Health, Inc. is 0.22x versus 53.54x for Pineapple, Inc.. Usually stocks with elevated PS ratios are considered overvalued.